Stay updated on Pembrolizumab + Imprime PGG in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page
- Check5 days agoChange DetectedNo textual changes are captured for this page in the provided dataset. The screenshots suggest a comparison, but no text changes are recorded in the change feed.SummaryDifference0.0%

- Check12 days agoChange DetectedThe study page now indicates that recruitment is closed to new participants, and adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a footer revision update (v3.6.0 replacing v3.5.5).SummaryDifference0.4%

- Check19 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5. This appears to be a small maintenance update rather than a alteration to the study details or user-facing information.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.5.4 was added and v3.5.3 was deleted, indicating a page version update.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s UI/version marker was bumped from “v3.5.2” to “v3.5.3,” indicating a site revision update rather than a change to the clinical study information.SummaryDifference0.0%

- Check69 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Imprime PGG in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.